相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Education of human natural killer cells by activating killer cell immunoglobulin-like receptors
Cyril Fauriat et al.
BLOOD (2010)
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation
Jeffrey M. Venstrom et al.
BLOOD (2010)
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2010)
NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
Janelle A. Olson et al.
BLOOD (2010)
Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells
Celine Cognet et al.
CLINICAL IMMUNOLOGY (2010)
Combined Genotypic and Phenotypic Killer Cell Ig-Like Receptor Analyses Reveal KIR2DL3 Alleles Displaying Unexpected Monoclonal Antibody Reactivity: Identification of the Amino Acid Residues Critical for Staining
Michela Falco et al.
JOURNAL OF IMMUNOLOGY (2010)
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
Daniela Pende et al.
BLOOD (2009)
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2009)
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction
Emanuela Marcenaro et al.
BLOOD (2009)
The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
Cameron S. Brandt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1:: implications for patient and donor suitability for haploidentical stem cell transplantations
Bree A. Foley et al.
BLOOD (2008)
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
Karl-Johan Malmberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions
Maelig Morvan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias
Alessandro Moretta et al.
IMMUNOLOGICAL REVIEWS (2008)
KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals
Bree Foley et al.
INTERNATIONAL IMMUNOLOGY (2008)
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3
Achim K. Moesta et al.
JOURNAL OF IMMUNOLOGY (2008)
KIR2DS1-positive NK cells mediate alloresponse against the C2HLA-KIR ligand group in vitro
Joseph H. Chewning et al.
JOURNAL OF IMMUNOLOGY (2007)
Prospects for the use of NK cells in immunotherapy of human cancer
Hans-Gustaf Ljunggren et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Cutting edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B
Hathairat Thananchai et al.
JOURNAL OF IMMUNOLOGY (2007)
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self
Loredana Ruggeri et al.
IMMUNOLOGICAL REVIEWS (2006)
Single-cell cloning of human, donor-derived antileukemia T-Cell lines for in vitro separation of graft-versus-leukemia effect from graft-versus-host reaction
Daniela Montagna et al.
CANCER RESEARCH (2006)
Medical progress: Hematopoietic stem-cell transplantation
EA Copelan
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction
D Pende et al.
BLOOD (2006)
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors
CA Stewart et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation
S Verheyden et al.
LEUKEMIA (2005)
Cellular ligands of activating NK receptors
C Bottino et al.
TRENDS IN IMMUNOLOGY (2005)
Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias
DW Beelen et al.
BLOOD (2005)
MHC class I molecules and KIRs in human history, health and survival
P Parham
NATURE REVIEWS IMMUNOLOGY (2005)
Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors
S Giebel et al.
BLOOD (2003)
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors
MD Chiesa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells
G Ferlazzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The genomic context of natural killer receptor extended gene families
J Trowsdale et al.
IMMUNOLOGICAL REVIEWS (2001)
NK cell recognition of non-classical HLA class I molecules
M López-Botet et al.
SEMINARS IN IMMUNOLOGY (2000)
分享论文
